Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Portfolio

Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.

More on the types of investments we make.

Here you can explore our current and past investments, filtered by issue area or investment type.

SD Biosensor

SD Biosensor received support from the foundation to make its COVID-19 Ag Rapid Diagnostic Test available to low- and middle-income countries. Making high-quality, affordable tests with results available in 15-30 minutes is a critical tool to fight the pandemic. Investment Read More

Press Release
Sera Prognostics Logo

Sera Prognostics

Sera Prognostics, based in Salt Lake City, UT, is developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications.

Press Release

Stellapps Technologies

Stellapps is focused on the development of integrated software and hardware tools that allow dairy processors to manage their supply chains. The primary use case of the Stellapps’ technologies is at milk collection centers where individual SHFs sell their milk. Read More

Press Release
News Story

SwipeRx

SwipeRx, formerly mClinica, is the is the largest network of pharmacies in southeast Asia connecting over 235,000 pharmacy professionals from 45,000 pharmacies.  SwipeRx pioneered the community-driven commerce model that unites the fragmented pharmacy channel on a single platform enabling them Read More

Synlogic Logo

Synlogic

Synlogic is a start-up company in Boston, developing a first-in-class synthetic biology platform for genetically engineering bacteria of the microbiome for delivery of therapeutics to the gut, initially focused on metabolic imbalance and inflammatory disease.

UNFPA Supplies

Alongside the UK’s Department for International Development, the foundation provided support to UNFPA Supplies to create a pool of flexible financing to improve reliable access to family planning commodities in low- and middle-income countries supported by UNFPA Supplies. Investment Date: Read More

Press Release
Unicef Logo

UNICEF Antivirals

The foundation provided support to UNICEF to create a pool of flexible financing to improve access to generic novel COVID-19 oral antivirals in low and middle-income countries.   Investment Date: March 2022

Unicef Logo

UNICEF OPV

The foundation provided a volume guarantee to Novartis to reduce the price of oral polio virus vaccines in the developing world.

Press Release
Unicef Logo

UNICEF VII

The foundation provided support to expand UNICEF’s Vaccine Independence Initiative. This program allows countries to bridge-finance the procurement of vaccines while they await budget funds to be available.

Press Release
Unicef Logo

UNICEF VII (2021)

The foundation provided support to expand UNICEF’s Vaccine Independence Initiative. This program allows countries to bridge-finance the procurement of vaccines and other health commodities and UNICEF to procure COVID commodities in advance of country demand materialization and procurement. The financing Read More